Credit Agricole’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2 Hold
1
﹤0.01% 1266
2024
Q4
$2 Hold
1
﹤0.01% 1276
2024
Q3
$4 Hold
1
﹤0.01% 1278
2024
Q2
$4 Hold
1
﹤0.01% 1103
2024
Q1
$4 Hold
1
﹤0.01% 951
2023
Q4
$5 Buy
+1
New +$4 ﹤0.01% 910
2023
Q3
Sell
-1
Closed -$7 942
2023
Q2
$7 Hold
1
﹤0.01% 693
2023
Q1
$8 Hold
1
﹤0.01% 660
2022
Q4
$19 Hold
1
﹤0.01% 709
2022
Q3
$0 Hold
1
﹤0.01% 689
2022
Q2
$0 Hold
1
﹤0.01% 697
2022
Q1
$0 Hold
1
﹤0.01% 722
2021
Q4
$0 Hold
1
﹤0.01% 707
2021
Q3
$0 Hold
1
﹤0.01% 685
2021
Q2
$0 Hold
1
﹤0.01% 688
2021
Q1
$0 Hold
1
﹤0.01% 648
2020
Q4
$0 Hold
1
﹤0.01% 570
2020
Q3
$0 Hold
1
﹤0.01% 509
2020
Q2
$0 Hold
1
﹤0.01% 471
2020
Q1
$0 Hold
1
﹤0.01% 497
2019
Q4
$0 Hold
1
﹤0.01% 483
2019
Q3
$0 Hold
1
﹤0.01% 531
2019
Q2
$0 Hold
1
﹤0.01% 493
2019
Q1
$0 Hold
1
﹤0.01% 474
2018
Q4
$0 Hold
1
﹤0.01% 469
2018
Q3
$0 Hold
1
﹤0.01% 437
2018
Q2
$0 Hold
1
﹤0.01% 374
2018
Q1
$0 Buy
+1
New +$247 ﹤0.01% 350

Other funds holding EDSA

Credit Agricole's EDSA Position: Q1 2025 in Review

Credit Agricole held its Edesa Biotech (EDSA) position steady in Q1 2025 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Credit Agricole first reported a position in EDSA in Q1 2018 and has held it in 28 quarters since. The position peaked at $19 in Q4 2022. 20 funds tracked by Wall St. Rank hold EDSA as of Q1 2025.

  • Credit Agricole held 1 share of Edesa Biotech worth $2 as of Q1 2025.
  • Credit Agricole left its Edesa Biotech share count unchanged in Q1 2025.
  • Edesa Biotech made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1266 holding.
  • Credit Agricole first reported a position in Edesa Biotech in Q1 2018 and has held it in 28 quarters since.
  • Credit Agricole's Edesa Biotech position peaked at $19 in Q4 2022.
  • 20 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.